OCA

Octagon Capital Advisors Portfolio holdings

AUM $641M
1-Year Est. Return 327.85%
This Quarter Est. Return
1 Year Est. Return
+327.85%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$641M
AUM Growth
+$185M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
33
New
Increased
Reduced
Closed

Top Buys

1
+$9.58M
2
+$9.18M
3
+$5.32M
4
ABVX
Abivax
ABVX
+$4.92M
5
PEPG icon
PepGen
PEPG
+$3.23M

Top Sells

1
+$31.9M
2
+$23.6M
3
+$19.4M
4
NUVB icon
Nuvation Bio
NUVB
+$18.7M
5
TRML
Tourmaline Bio
TRML
+$14.5M

Sector Composition

1 Healthcare 99.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NUVB.WS icon
26
Nuvation Bio Inc Warrants
NUVB.WS
$88.6M
$385K 0.06%
104,112
-50,000
ERAS icon
27
Erasca
ERAS
$848M
– –
-700,000
MLTX icon
28
MoonLake Immunotherapeutics
MLTX
$951M
– –
-148,000
SPRY icon
29
ARS Pharmaceuticals
SPRY
$915M
– –
-1,350,000
TRML
30
DELISTED
Tourmaline Bio
TRML
– –
-905,000
VRNA
31
DELISTED
Verona Pharma
VRNA
– –
-337,000
ATYR
32
aTyr Pharma
ATYR
$75M
– –
-3,820,000
KLRS
33
Kalaris Therapeutics
KLRS
$104M
– –
-360,000
1
2